טוען...
Minimal Residual Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Minimal residual disease (MRD), both before and after transplant, is a clinically important yet relatively poorly defined aspect of allogeneic hematopoietic stem cell transplantation (alloHSCT). The clinical relevance of MRD in the context of alloHSCT has been demonstrated by its association with th...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056549/ https://ncbi.nlm.nih.gov/pubmed/21047560 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.10.031 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|